Neoadjuvant therapy with Docetaxel (TAX) and Cisplatin (CIS) in patients (pts) with non-small cell lung cancer (NSCLC), stage IIIA, N2 is highly active with few toxicitiesDaniel C Betticher,Shufang F Hsu Schmitz,Yves P Gauthier,Christian Von Briel,A Roth,Anastase Spiliopoulos,Miklos Pless,Rolf A Stahel,Walter Weder,Martin Totsch,Thomas Cerny,H B RisLung Cancer（2000）引用 3|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
